J&J COVID-19 vaccine benefits ‘far outweigh’ risks, CDC panel says after reports of Guillain …

jj covid 19 vaccine benefits far outweigh risks cdc panel says after reports of guillain barre syndrome

Sumary of J&J COVID-19 vaccine benefits ‘far outweigh’ risks, CDC panel says after reports of Guillain-Barré syndrome:

  • An advisory panel to the Centers for Disease Control and Prevention (CDC) said the benefits of COVID-19 vaccines “far outweigh” potential risks amid an ongoing review of reports of a rare nerve disorder in a small fraction of J&J jab recipients.
  • “Dr. Nicola Klein with the Kaiser Permanente Vaccine Study Center noted eight confirmed cases of GBS following J&J vaccination amid a backdrop of over 345,000 doses administered, per data collected through the Vaccine Safety Datalink.
  • The FDA had revised the vaccine’s accompanying fact sheets to reflect an increased risk of the disorder in the 42 days after vaccination.
  • JOHNSON COVID-19 VACCINE LINK TO RARE DISORDERGuillain-Barré syndrome (GBS) occurs when a person’s immune system and inflammation damage the nerves, spurring muscle weakness and in some severe cases, paralysis, according to the CDC.
  • Triggers for the syndrome include recent respiratory or gastrointestinal infection weeks before symptoms, or other viral infections like the flu and Zika virus.

Want to know more click here go to source.

From -

Close
Generic selectors
Exact matches only
Search in title
Search in content

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close